HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Additional non-oral options could provide more manageable forms of PrEP treatment for patients, potentially increasing global uptake of PrEP in the future.
[[thumbnail_alt_text]]
Further, the study showed cabotegravir was 89% more effective than daily oral FTC/TDF for pre-exposure prophylaxis (PrEP).
[[thumbnail_alt_text]]
Further, the study showed cabotegravir was 89% more effective than daily oral FTC/TDF for pre-exposure prophylaxis (PrEP).
[[thumbnail_alt_text]]
The US Department of Health & Human Services released guidance at the beginning of the pandemic clarifying guidelines regarding best practices in HIV care.
[[thumbnail_alt_text]]
This activity is supported by an educational grant from Janssen Therapeutics, division of Janssen Products, LP.
[[thumbnail_alt_text]]
Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.
[[thumbnail_alt_text]]
Although HIV self-tests are available for retail purchase by consumers, the CDC encourages health departments to consider self-testing as an additional strategy to reach individuals most affected by the virus.
[[thumbnail_alt_text]]
This activity is supported by an educational grant from Janssen Therapeutics, division of Janssen Products, LP.
[[thumbnail_alt_text]]
Insurance companies are currently investigating the option of modifying which medications they will cover for HIV pre-exposure prophylaxis (PrEP) therapy, with broad implications for patient access.
[[thumbnail_alt_text]]
Learn how retail or specialty pharmacy distribution can affect access to these important drugs.
[[thumbnail_alt_text]]
Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.
[[thumbnail_alt_text]]
Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.